Angiotensin‐converting enzyme inhibitor works as a scar formation inhibitor by down‐regulating Smad and TGF‐β‐activated kinase 1 (TAK1) pathways in mice
Wei‐Qiang Tan(Cedars-Sinai Medical Center), Kenneth E. Bernstein(Cedars-Sinai Medical Center), Tuantuan Zhao(Mayo Clinic in Arizona), Peng Shi(Second Affiliated Hospital of Zhejiang University), Zakir Khan(Cedars-Sinai Medical Center), Xiao Z. Shen(Cedars-Sinai Medical Center), You Li(Nantong University), Liang Li(Chongqing Medical University), Liyun Zhang(Shanxi Medical University), Ji‐Hua Xu(Sir Run Run Shaw Hospital), Jorge F. Giani(Cedars-Sinai Medical Center), Qing‐Qing Fang(Sir Run Run Shaw Hospital), Ellen A. Bernstein(Emory University)
Cited by 58
Related Papers
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488